Ocugen Receives Health Canada Approval To Initiate Phase 3 LiMeliGhT Trial For OCU400

RTTNews | 59天前
Ocugen Receives Health Canada Approval To Initiate Phase 3 LiMeliGhT Trial For OCU400

(RTTNews) - Biotechnology company Ocugen, Inc. (OCGN) announced Monday that Health Canada provided a "No Objection Letter" to initiate the OCU400 Phase 3 liMeliGhT clinical trial in Canada. OCU400 is a modifier gene therapy product candidate being developed for retinitis pigmentosa (RP).

Currently there are approximately 10,000 patients in Canada with RP and 1.6 million patients globally. The Phase 3 study in Canada will enroll up to 50 subjects across a maximum of 5 sites for the liMeliGhT clinical trial.

The Health Canada trial will run in parallel with the U.S. FDA trial.

The primary endpoint for the study is an enhanced sensitive and specific measurement of functional vision test - Luminance Dependent Navigation Assessment (LDNA). Specifically, the primary endpoint is a measurement of the change in functional vision from baseline to week 52 as measured by the ability of a study participant to navigate through a maze (the LDNA).

read more
U.S. New Home Sales Surge More Than Expected To Highest Level In Over A Year

U.S. New Home Sales Surge More Than Expected To Highest Level In Over A Year

New home sales in the U.S. rebounded by much more than expected in the month of September, according to a report released by the Commerce Department on Thursday. The Commerce Department said new home sales surged by 4.1 percent to an annual rate of 738,000 in September after tumbling by 2.3 percent to a revised rate of 709,000 in August.
RTTNews | 4小时54分钟前
Unilever Stock Up On Q3 Underlying Sales Growth, Outlook

Unilever Stock Up On Q3 Underlying Sales Growth, Outlook

Shares of Unilever Plc were gaining around 3 percent in the Amsterdam trading as well as on the NYSE on Thursday after the consumer goods major reported higher underlying sales growth in its third quarter, and maintained its fiscal 2024 growth forecast. The third-quarter sales, on a reported basis, remained flat.
RTTNews | 5小时13分钟前
Intel Wins EU Court Battle As EUR 1.06 Bln Fine Annulled

Intel Wins EU Court Battle As EUR 1.06 Bln Fine Annulled

Intel Corp. has won a long-running court battle in the European Union, where the Court of Justice, Europe's top court, upheld the annulment by the General Court of a 1.06 billion euros fine imposed by the Commission on the chipmaker. The European regulator had alleged an abuse of a dominant position on the part of Intel.
RTTNews | 5小时39分钟前
U.S. Weekly Jobless Claims Unexpectedly See Further Downside

U.S. Weekly Jobless Claims Unexpectedly See Further Downside

After reporting an unexpected pullback by first-time claims for U.S. unemployment benefits in the previous week, the Labor Department released a report on Thursday showing initial jobless claims saw further downside in the week ended October 19th. The report said initial jobless claims fell to 227,000, a decrease of 15,000 from the previous week's revised level of 242,000.
RTTNews | 5小时52分钟前
U.S. Weekly Jobless Claims Unexpectedly Fall To 227,000

U.S. Weekly Jobless Claims Unexpectedly Fall To 227,000

After reporting an unexpected pullback by first-time claims for U.S. unemployment benefits in the previous week, the Labor Department released a report on Thursday showing initial jobless claims saw further downside in the week ended October 19th.
RTTNews | 6小时53分钟前
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Higher crude oil and bullion prices point to a positive start for the Canadian market on Thursday. Investors are likely to track quarterly earnings updates from Canadian and U.S. companies.
RTTNews | 6小时54分钟前